Evaluation of overall survival according to myelodysplastic syndrome-specific comorbidity index in a large series of myelodysplastic syndromes

Lignende værker

• MDS-specific comorbidity index is useful to identify myelodysplastic patients who can have better outcome with 5-azacitidine
  af: Breccia, Massimo, et al.
  Udgivet: (2012)
• Haematological improvement as a beneficial effect during deferasirox treatment in transfusion-dependent patients with myelodysplastic syndrome
  af: Molica, Matteo, et al.
  Udgivet: (2014)
• Low Incidence Rate of Opportunistic and Viral Infections During Imatinib Treatment in Chronic Myeloid Leukemia Patients in Early and Late Chronic Phase.
  af: Breccia, Massimo, et al.
  Udgivet: (2011)
• Systematic review of dasatinib in chronic myeloid leukemia
  af: Breccia, Massimo, et al.
  Udgivet: (2013)
• Association of Comorbidities With Overall Survival in Myelodysplastic Syndrome: Development of a Prognostic Model
  af: Naqvi, Kiran, et al.
  Udgivet: (2011)